For decades, discovery has relied on "brute force" mass-screening – testing thousands of random compounds hoping one will ...

All key players - CMOs, CDMOs, pharmaceutical companies, service and equipment vendors, government, and institutions - ...

Sun Pharma has downplayed a rumour that it is in talks to acquire women's health specialist Organon, after a report suggested ...

Male infertility accounts for about 50% of infertility struggles, but research spending for men accounts for just 7%. That’s ...

The EMA has started its review of Daiichi Sankyo and AstraZeneca's Enhertu as a first-line therapy for HER2-positive breast ...

The Bio-Hermes-002 study, involving 1,000 volunteers aged over 60 in the UK, US and Canada, is using finger-prick testing to ...

A CDMO championing a commitment to patients may sound like lip service or branding, but truly patient-centric CDMOs offer ...

The decision means Northern Ireland remains the only country in the UK where patients with this stage of prostate cancer are ...

The Supreme Court of the US (SCOTUS) has agreed to hear a patent dispute between Amarin and Hikma that could have ...

Historically, JPM week has been marked by at least a handful of high-dollar, high-profile acquisition events. This year we ...

Taking control of Ocular would also give Sanofi access to its drug delivery platform Elutyx, which could have applications ...

What the deals have in common is price reductions for Medicaid, MFN prices for new launches, and discounts for self-paying ...